STRS Ohio’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-385
Closed -$76K 2149
2021
Q4
$76K Sell
385
-209
-35% -$49.3K ﹤0.01% 1945
2021
Q3
$147K Hold
594
﹤0.01% 1862
2021
Q2
$246K Buy
+594
New +$235K ﹤0.01% 1756
2018
Q3
Sell
-89
Closed -$181K 2113
2018
Q2
$181K Sell
89
-776
-90% -$1.77M ﹤0.01% 1769
2018
Q1
$1.91M Buy
865
+93
+12% +$237K 0.01% 634
2017
Q4
$1.78M Buy
772
+85
+12% +$173K 0.01% 644
2017
Q3
$1.22M Buy
687
+116
+20% +$162K 0.01% 769
2017
Q2
$777K Buy
571
+116
+25% +$140K ﹤0.01% 988
2017
Q1
$536K Buy
455
+131
+40% +$134K ﹤0.01% 1312
2016
Q4
$259K Hold
324
﹤0.01% 1506
2016
Q3
$284K Buy
+324
New +$235K ﹤0.01% 1475
2015
Q2
Sell
-1,050
Closed -$1.64M 1866
2015
Q1
$1.64M Sell
1,050
-54
-5% -$71.2K 0.01% 636
2014
Q4
$1.31M Sell
1,104
-602
-35% -$402K 0.01% 684
2014
Q3
$793K Buy
+1,706
New +$787K ﹤0.01% 877
2013
Q4
Sell
-239
Closed -$84K 1744
2013
Q3
$84K Buy
+239
New +$88.8K ﹤0.01% 1663

Other funds holding BLUE

STRS Ohio's BLUE Position: Q1 2022 in Review

STRS Ohio sold out of bluebird bio (BLUE) in Q1 2022, closing a stake of 385 shares — an estimated $76K sold.

STRS Ohio first reported a position in BLUE in Q3 2013 and held it in 15 quarters. The position peaked at $1.91M in Q1 2018. 174 funds tracked by Wall St. Rank hold BLUE as of Q1 2022.

  • STRS Ohio reported no remaining bluebird bio position as of Q1 2022 after selling out during the quarter.
  • STRS Ohio sold 385 bluebird bio shares in Q1 2022, an estimated $76K.
  • STRS Ohio first reported a position in bluebird bio in Q3 2013 and held it in 15 quarters.
  • STRS Ohio's bluebird bio position peaked at $1.91M in Q1 2018.
  • 174 funds tracked by Wall St. Rank held bluebird bio as of Q1 2022.

Based on STRS Ohio's 13F filing for Q1 2022, filed 21 Apr 2022.